Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.950
+0.050 (1.72%)
Jan 22, 2025, 4:00 PM EST - Market closed
Cyclerion Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 22, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 7 | 8 | 29 | 75 | 104 | 75 | |
| Market Cap Growth | -20.97% | -71.30% | -61.69% | -28.31% | 39.09% | - | |
| Enterprise Value | 4 | -1 | 8 | 16 | 84 | 32 | |
| Last Close Price | 2.90 | 3.35 | 13.12 | 34.40 | 61.20 | 54.40 | |
| PS Ratio | 37.32 | - | 96.10 | 18.90 | 45.26 | 16.58 | |
| PB Ratio | 0.90 | 0.73 | 2.73 | 1.54 | 1.75 | 0.76 | |
| P/TBV Ratio | 0.79 | 0.73 | 2.73 | 1.54 | 1.75 | 0.76 | |
| EV/Sales Ratio | 23.03 | - | 27.39 | 3.93 | 36.37 | 7.18 | |
| Debt / Equity Ratio | - | - | - | - | 0.77 | 0.76 | |
| Asset Turnover | 0.02 | - | 0.01 | 0.05 | 0.02 | 0.05 | |
| Quick Ratio | 4.17 | 3.63 | 1.77 | 4.88 | 3.22 | 5.28 | |
| Current Ratio | 5.07 | 3.85 | 1.94 | 5.00 | 3.45 | 5.55 | |
| Return on Equity (ROE) | -50.13% | -115.85% | -62.17% | -95.87% | -98.97% | -281.86% | |
| Return on Assets (ROA) | -30.72% | -38.34% | -29.94% | -38.86% | -34.34% | -80.62% | |
| Return on Capital (ROIC) | -35.15% | -55.47% | -39.48% | -44.24% | -37.44% | -96.96% | |
| Earnings Yield | -71.95% | -64.25% | -154.44% | -69.32% | -74.86% | -164.64% | |
| FCF Yield | -84.94% | -259.37% | -142.29% | -49.02% | -71.22% | -146.02% | |
| Buyback Yield / Dilution | -10.09% | -7.59% | -11.03% | -28.75% | -11.04% | - | |
| Total Shareholder Return | -10.09% | -7.59% | -11.03% | -28.75% | -11.04% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.